Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,119.59
(
-0.76%
)
US TECH 100
26,170.00
(
-1.50%
)
Dow Jones
49,223.91
(
-0.18%
)
Brent Oil
104.31
(
2.15%
)
Bitcoin
76,020.06
(
-1.75%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Protector

Send PM Follow Ignore
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Protector

Re: ku post# 260890

Tuesday, 04/05/2016 5:17:45 PM

Tuesday, April 05, 2016 5:17:45 PM

Post# of 347009
ku, do not complain about that. CEO King EXPLICITLY said that they would not look at the PPS but run the company in function of the Science and clinical programs until they got to a commercial phase (were they are not).

We are invested in a Small Cap Biotech and you cannot apply the PPS rules to it of quarterly reporting companies that are judge by turn-over/revenue/profits/etc.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote